Lionel Ades, Agnès Guerci-Bresler, Pascale Cony-Makhoul, Laurence Legros, Marie Sebert, Thorsten Braun, Jacques Delaunay, Kristell Desseaux, Sylvie Chevret, and Pierre Fenaux. 2019. “A Phase II Study of the Efficacy and Safety of an Intensified Schedule of Azacytidine in Intermediate-2 and High-Risk Patients With Myelodysplastic Syndromes: A Study by the Groupe Francophone Des Myelodysplasies (GFM)”. Haematologica 104 (4). Pavia, Italy, e131-e133. https://doi.org/10.3324/haematol.2018.203885.